MFDS — authorised 24 April 2024
- Marketing authorisation holder: ALEMBIC THERAP
- Status: likely_approved
🇰🇷 Pivamdinocillin in South Korea
MFDS authorised Pivamdinocillin on 24 April 2024
Marketing authorisation
Pivamdinocillin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Pivamdinocillin approved in South Korea?
Yes. MFDS authorised it on 24 April 2024.
Who is the marketing authorisation holder for Pivamdinocillin in South Korea?
ALEMBIC THERAP holds the South Korean marketing authorisation.